The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study

Table 5 Comparison of organ damage and failure related to DIC among the original and adjusted cohorts

	rhTM group	Control group	Original cohorts		Adjusted cohorts
	(n = 37)	(n = 29)	Odds ratio (95 % CI)^a	P value^a	Odds ratio (95 % CI)^a	P value^a
Cardiac, n (%)	1 (2.7)	1 (3.4)	0.778 (0.047–12.990)	0.861	0.970 (0.114–8.283)	0.978
Respiratory, n (%)	3 (8.1)	2 (6.9)	1.191 (0.186–7.645)	0.854	0.409 (0.115–1.460)	0.186
Renal, n (%)	3 (8.1)	3 (10.3)	0.765 (0.143–4.102)	0.754	0.737 (0.219–2.474)	0.621
Liver, n (%)	2 (5.4)	7 (24.1)	0.180 (0.034–0.944)	0.043	0.587 (0.216–1.595)	0.296

^aOdds ratio and P value estimated by logistic regression analysis. DIC disseminated intravascular coagulation, rhTM recombinant human soluble thrombomodulin

ISSN: 1364-8535